NL
Na Li
Senior Statistical Analyst at Xenoport,
View Na's Contact Info for Free. Sign Up and Get 50 Free Contacts Per Month.Get Started for Free
Work Experience
Senior Statistical Analyst
Nov 2007 - Present · 17 years and 2 months
Company Details
51-200 Employees
XenoPort, Inc. is a biopharmaceutical company focused on developing and commercializing a portfolio of internally discovered product candidates for the potential treatment of neurological disorders. Horizant® (gabapentin enacarbil) Extended-Release Tablets is approved and being marketed in the United States by XenoPort. Regnite® (gabapentin enacarbil) Extended-Release Tablets is approved and being marketed in Japan by Astellas Pharma Inc. XenoPort holds all other world-wide rights to gabapentin enacarbil. XenoPort's pipeline of product candidates includes potential treatments for patients with Parkinson's disease, relapsing-remitting multiple sclerosis and psoriasis.
Year Founded
1999
Social Media
LinkedinFacebookTwitter
Industry
Pharmaceutical Manufacturing, Hospitals & Clinics
HQ Location
--
Keywords
--
Discover More About Cleveland Clinic

Find verified contacts of Na Li in seconds from 700M people profiles. Start now!

No Credit Card Needed. By signing up, you understand and agree to Futern's Terms and Policy.